PTGX is currently covered by 7 analysts with average potential upside of $21.48 (109.72%) backed by 17 price targets and 52 ratings. Documented since 06-Sep-2016. Analyst's average stock valuation to be materialised ratio is 42.69% with an average time for price targets to be met of 183.56 days.
Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 16-Mar-2023.
Highest price target for PTGX is 49, Lowest price target is 9, average price target is 29.
Currently, out of the existing stock ratings of PTGX - 30 which are a Buy (78.95%), 8 which are a Hold (21.05%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
38
$15.51 (68.96%)
50
15 days ago
6/10 (60%)
$13.06 (68.39%)
199
Buy
45
$22.51 (100.09%)
55
11 months 5 days ago
0/2 (0%)
$31.37 (237.85%)
Buy
70
11 months 17 days ago
1/8 (12.5%)
$24.63 (98.50%)
57
Buy
93
$70.51 (313.52%)
93
11 months 18 days ago
0/7 (0%)
$57.99 (236.55%)
Buy
35
$12.51 (55.62%)
50
11 months 20 days ago
6/9 (66.67%)
$10.51 (55.96%)
457
What is PTGX(Protagonist Therapeutics, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on PTGX(Protagonist Therapeutics, Inc) with a proven track record?
